Clinical trial
A Phase II Study of Docetaxel, Oxaliplatin and S-1 (DOS) in Patients With Advanced Gastric Cancer
NCT00525005 is registered in ClinicalTrials.gov with Hallym University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Docetaxel, Oxaliplatin and S-1 (DOS) in Patients With Advanced Gastric Cancer
- Lead sponsor
- Hallym University Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- June 30, 2010
- Enrollment
- 44 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.